crb1.org - A CURE IS IN SIGHT

A CURE IS IN SIGHT!

The Curing Retinal Blindness Foundation hosted it's
first CRB1 research meeting on March 23,2013
at Shriners Hospitals for Children Pediatric Research Center
at Temple University School of Medicine.
The meeting was attended by incredible professionals and families of CRB1 patients. It was a fantastic day! Details on the plan to move CRB1 forward will be coming soon!

CRB1 RESEARCH IS GETTING ATTENTION AND MOVING ALONG!
Foundation Fighting Blindness is paying attention to CRB1! From their site published 7/28/11:
Gene Therapy for LCA and Autosomal Recessive Retinitis Pigmentosa — Approximately 10-15 percent of LCA cases and 3-4 percent of RP cases are caused by variations in the gene CRB1. While there is currently no treatment for these forms of disease, progress is being made on the gene therapy front for them. Dr. Jan Wijnholds of The Netherlands Institute for Neurosciences, in collaboration with Dr John Flannery at the University of California, Berkeley, is developing an AAV gene therapy that can safely and effectively deliver a healthy gene to the inner cells in the retina that are affected by the CRB1 variations. The researchers are hopeful this work could lead to future clinical trials for these diseases.

The team at University of PENN opened an incredible door in 2009 with their gene replacement therapy breakthough for LCA (gene-RPE65)!
Click on the link below to watch the video of Corey Haas, a child undergoing gene repacement therapy for the RPE65 gene mutation of LCA!
http://www.youtube.com/watch?v=FyR99anGBqE

MORE UPDATES COMING SOON!!!